CG Oncology (CGON) Leases (2023 - 2025)
Historic Leases for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $4.2 million.
- CG Oncology's Leases rose 142836.36% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 142836.36%. This contributed to the annual value of $221000.0 for FY2024, which is 4763.03% down from last year.
- CG Oncology's Leases amounted to $4.2 million in Q3 2025, which was up 142836.36% from $965000.0 recorded in Q2 2025.
- In the past 5 years, CG Oncology's Leases registered a high of $4.2 million during Q3 2025, and its lowest value of $221000.0 during Q4 2024.
- In the last 3 years, CG Oncology's Leases had a median value of $395000.0 in 2023 and averaged $977000.0.
- Its Leases has fluctuated over the past 5 years, first crashed by 4763.03% in 2024, then surged by 142836.36% in 2025.
- Over the past 3 years, CG Oncology's Leases (Quarter) stood at $422000.0 in 2023, then plummeted by 47.63% to $221000.0 in 2024, then soared by 1801.81% to $4.2 million in 2025.
- Its Leases stands at $4.2 million for Q3 2025, versus $965000.0 for Q2 2025 and $1.0 million for Q1 2025.